PD Dr. Gerlig Widmann

09/2021

PD Dr. Gerlig Widmann

The COVID-19 template enables us to perform a structured radiological and clinical assessment of SARS‑CoV‑2 positive patients and is a valuable tool for monitoring and follow-up studies.

Related Resources

New iRECIST Oncologic Response Criteria already in clinical use at the University Medical Center – Tübingen, Germany

05/2017

Shortly following the release of the new iRECIST- oncologic response criteria (Lancet Oncology, March 2017) the University Medical Center in Tübingen,…

Mrs. Kelie Luby joins Mint Medical's team

11/2016

Mrs. Kelie Luby will join Mint Medical’s team from January 2017 as new Vice President Clinical Trials Software and will be introduced at the upcoming…

Novel oncologic therapy response criteria (iRECIST and more)

11/2016

Advances in oncology therapies, such as novel immune-related agents, require adapted and refined criteria and guidelines for the assessment and…

Name	Purpose	Lifetime	Type	Provider
CookieConsent	Saves your consent to using cookies.	1 year	HTML	Website
fe_typo_user	Assigns your browser to a session on the server.	session	HTTP	Website

Name	Purpose	Lifetime	Type	Provider
_pk_id	Used to store a few details about the user such as the unique visitor ID.	13 months	HTML	Matomo
_pk_ref	Used to store the attribution information, the referrer initially used to visit the website.	6 months	HTML	Matomo
_pk_ses	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo
_pk_cvar	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo
_pk_hsr	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo

Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.